Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy sampling.

Literature DB >> 27644935

Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy sampling.

Declan G Murphy^1,2, Jeremy P Grummet³.

Abstract

Mesh：

Year: 2016 PMID： 27644935 DOI： 10.1038/nrurol.2016.176

Source DB: PubMed Journal: Nat Rev Urol ISSN： 1759-4812 Impact factor: 14.432

× No keyword cloud information.

6 in total

Review 1. Transperineal biopsy of the prostate--is this the future?

Authors: Dwayne T S Chang; Benjamin Challacombe; Nathan Lawrentschuk
Journal: Nat Rev Urol Date: 2013-09-24 Impact factor: 14.432

Review 2. Reducing infection rates after prostate biopsy.

Authors: Florian M E Wagenlehner; Adrian Pilatz; Przemyslaw Waliszewski; Wolfgang Weidner; Truls E Bjerklund Johansen
Journal: Nat Rev Urol Date: 2014-01-14 Impact factor: 14.432

Review 3. Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

Authors: Jeremy P Grummet; Mahesha Weerakoon; Sean Huang; Nathan Lawrentschuk; Mark Frydenberg; Daniel A Moon; Mary O'Reilly; Declan Murphy
Journal: BJU Int Date: 2014-02-19 Impact factor: 5.588

4. A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.

Authors: Paul R Womble; Susan M Linsell; Yuqing Gao; Zaojun Ye; James E Montie; Tejal N Gandhi; Brian R Lane; Frank N Burks; David C Miller
Journal: J Urol Date: 2015-04-17 Impact factor: 7.450

5. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

Authors: Florian M E Wagenlehner; Edgar van Oostrum; Peter Tenke; Zafer Tandogdu; Mete Çek; Magnus Grabe; Björn Wullt; Robert Pickard; Kurt G Naber; Adrian Pilatz; Wolfgang Weidner; Truls E Bjerklund-Johansen
Journal: Eur Urol Date: 2012-06-12 Impact factor: 20.096

6. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Authors: Michael A Liss; Stephen A Taylor; Deepak Batura; Deborah Steensels; Methee Chayakulkeeree; Charlotte Soenens; G Gopal Rao; Atreya Dash; Samuel Park; Nishant Patel; Jason Woo; Michelle McDonald; Unwanaobong Nseyo; Pooya Banapour; Stephen Unterberg; Thomas E Ahlering; Hendrik Van Poppel; Kyoko Sakamoto; Joshua Fierer; Peter C Black
Journal: J Urol Date: 2014-06-10 Impact factor: 7.450

6 in total

4 in total

Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy sampling.

Review 1. Transperineal biopsy of the prostate--is this the future?

Review 2. Reducing infection rates after prostate biopsy.

Review 3. Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

4. A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.

5. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

6. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Review 1. Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Review 2. Magnetic Resonance-Guided Prostate Ablation.

3. Transperineal versus transrectal multi-parametric magnetic resonance imaging fusion targeted prostate biopsy.

Review 4. Transperineal vs. transrectal biopsy in MRI targeting.